Esperion Therapeutics
ESPR
#6431
Rank
NZ$1.31 B
Marketcap
NZ$5.52
Share price
-1.20%
Change (1 day)
73.69%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -NZ$49.04 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are NZ$0.30 Billion. In 2024 the company made an earning of NZ$12.55 Million, an increase over its 2023 earnings that were of -NZ$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$49.04 Million-490.51%
2024 NZ$12.55 M-104.99%
2023 -NZ$0.26 Billion-15.03%
2022 -NZ$0.3 Billion-20.61%
2021 -NZ$0.38 Billion84.28%
2020 -NZ$0.21 Billion35.75%
2019 -NZ$0.15 Billion-55.71%
2018 -NZ$0.34 Billion19.57%
2017 -NZ$0.29 Billion125.39%
2016 -NZ$0.13 Billion51.43%
2015 -NZ$82.41 Million36.45%
2014 -NZ$60.4 Million43.55%
2013 -NZ$42.08 Million145.26%
2012 -NZ$17.16 Million
2002 -NZ$48.91 Million-7.81%
2001 -NZ$53.05 Million15.03%
2000 -NZ$46.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$19.82 B-43,290.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$8.74 B-19,161.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-NZ$0.87 Billion 1,790.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$0.12 Billion 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$8.33 M-118.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.13 B-2,575.39%๐Ÿ‡บ๐Ÿ‡ธ USA